Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 48

Sort by

Sort Order Select

Journal Articles

Comparison of Clinical Evolution of Children with Sickle Cell Disease before and after Treatment with Hydroxyurea at Saint Damien Hospital, Tabarre-Haiti,2013-2018

Nora St Victor Dély, MD, Ofelia A. Alvarez, MD, Vanessa J Dor, MD, Emmeline Lerebours, MD

Blood (2019) 134 (Supplement_1): 2306.

https://doi.org/10.1182/blood-2019-124105

Published: 2019

Journal Articles

A Study of Haemostatic Parameters in Patients with Philadelphia-Negative Myeloproliferative Neoplasms. Correlation with, Clinical, Laboratory, Molecular, and Treatment Characteristics

Nefeli Giannakopoulou, Marianna Politou, MD, Panagiotis Theodorou Diamantopoulos, MD PhD, Dimitris Korakakis, Maria Efstathopoulou, Theodora Kassi, Christina-Nefeli Kontandreopoulou, Katerina Zoi, PhD, Andreas Giannopoulos, BSc, MSc, Maria Dimou, Panayiotis Panayiotidis, MD PhD, Nora-Athina Viniou, MD

Blood (2018) 132 (Supplement 1): 4304.

https://doi.org/10.1182/blood-2018-99-116660

Published: 2018

Journal Articles

Evaluation of Infusion Reactions in Patients Receiving Daratumumab Post-Implementation of an Augmented Pre- and Peri-Medication Regimen

Patrick McBride, PharmD, Houry Leblebjian, PharmD, Paul Richardson, Jacob Laubach, MD, Hillary Prescott, PharmD

Blood (2018) 132 (Supplement 1): 3234.

https://doi.org/10.1182/blood-2018-99-111361

Published: 2018

Journal Articles

Indirect Comparison Using Individual Patient Level Data Comparing Efficacy and Safety of a Daratumumab Monotherapy Vs. EU Approved Comparator Therapies in Patients with Multiple Myeloma

Irina Demmer, Susanne Huschens, Dietrich Potthoff, Jörg Tomeczkowski, Christian Englisch, Pushpike Thilakarathne, Joris Diels, Shaji K. Kumar, MD, Brian GM Durie, MD, Lewin Eisele

Blood (2018) 132 (Supplement 1): 3541.

https://doi.org/10.1182/blood-2018-99-116884

Published: 2018

Journal Articles

Successful Field Test of a Combined Health Access Strategy and Novel Device to Screen for Sickle Cell Disease (SCD) in Rural Sub-Saharan Africa

Catherine Mupela Chunda-Liyoka, MD MSc, Ashok A Kumar, PhD BS, MS, Pauline M Sambo, MD, Felicity Lubinda, Tyler Humpton, Pauline Okuku, MSc, Chimuka Miyanda, Bsc, Justine Mulindwa, MD, Judy Im I, Kerry Maguire, MPH, George M Whitesides, Prof., Thomas P. Stossel, MD

Blood (2018) 132 (Supplement 1): 316.

https://doi.org/10.1182/blood-2018-99-114625

Published: 2018

Journal Articles

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

Yutaka Niihara, MD, Charles William Stark, PharmD, Rafael Razon, MD, Lan T Tran, MPH, Joseph M Becerra, PharmD, Eduard H. Panosyan, MD, Joseph Louis Lasky, MD

Blood (2018) 132 (Supplement 1): 1065.

https://doi.org/10.1182/blood-2018-99-119720

Published: 2018

Journal Articles

Black Patients Experience Highest Rates of Specific Cancer-Associated Venous Thromboembolism: A Study Based at a Large Safety-Net Hospital in New England

Nana Oduraa Addo-Tabiri, MD PhD, Rani Chudasama, MD, Rhythm Vasudeva, MBChB, Orly Leiva, MD, Brenda Garcia, MD, Jonathan Ravid, BS, Bunze Tamala, BS, Linda Rosen, MSEE, Mostafa Belghasem, MD PhD, Janice Weinberg, PhD, Ryan Ferguson, MPH, Brett Johnson, PhD, Mary Brophy, MD MPH, Vipul Chitalia, MD PhD

Blood (2018) 132 (Supplement 1): 496.

https://doi.org/10.1182/blood-2018-99-115605

Published: 2018

Journal Articles

Practice and Correlates of Cancer Associated Thrombosis: The Impact of Socioeconomic Status

Jordan K. Schaefer, MD, Zhenke Wu, PhD, Mengbing Li, Jennifer J Griggs, MD MPH, Suman L. Sood, MD

Blood (2018) 132 (Supplement 1): 2225.

https://doi.org/10.1182/blood-2018-99-117931

Published: 2018

Journal Articles

Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia

Blood (2017) 130 (Supplement 1): 3181.

https://doi.org/10.1182/blood.V130.Suppl_1.3181.3181

Published: 2017

Journal Articles

Thrombin Generation As a Predictive Biomarker for Venous Thromboembolism in Patients with Pancreatic and Lung Cancer Undergoing Systemic Therapy

Michael Y. Cho, MD, Aderonke Ajala, MD, Lauren T. Salvatore, Deborah L. Ornstein, MD, Monic R. Drescher, MD

Blood (2017) 130 (Supplement 1): 1103.

https://doi.org/10.1182/blood.V130.Suppl_1.1103.1103

Published: 2017

Journal Articles

Exceptional Responses to Epigenetic Based Therapy in Pediatric and Young Adult Monosomy 7 MDS/AML Patients with and without TP53 Mutations

LaQuita M Jones, DO, Maureen M O'Brien, MD, Erin H. Breese, MD PhD, Karen Burns, MD, Jennifer Mangino, MD, Michael J. Absalon, MD PhD, Javier A. El-Bietar, MD, Michael Grimley, MD, Benjamin Mizukawa, MD, Lynn Lee, MD, John Peter Perentesis, MD, Christine L Phillips, MD

Blood (2017) 130 (Supplement 1): 3895.

https://doi.org/10.1182/blood.V130.Suppl_1.3895.3895

Published: 2017

Journal Articles

Coagulation Activation in Brain Neoplasms

Swaroopa Yerrabothala, MD, Brett L. Gourley, MD, James C Ford, PhD, Syed Rakin Ahmed, Stephen J Guerin, MD, Heather A Wishart, PhD, Camilo E Fadul, MD, Deborah L. Ornstein, MD

Blood (2017) 130 (Supplement 1): 3704.

https://doi.org/10.1182/blood.V130.Suppl_1.3704.3704

Published: 2017

Journal Articles

miRNA Profiling in Pediatric T-ALL with Use of Next-Generation Sequencing: Focus on T-ALL Pathobiology and Heterogeneity

Małgorzata Dawidowska, PhD, Bronisława Szarzyńska-Zawadzka, Roman Jaksik, PhD, Monika Drobna, Maria Kosmalska, Sędek Łukasz, PhD, Tomasz Szczepański, MD PhD, Michał Witt, MD PhD

Blood (2017) 130 (Supplement 1): 1443.

https://doi.org/10.1182/blood.V130.Suppl_1.1443.1443

Published: 2017

Journal Articles

Mycafungin Prophylaxis for Adult Acute Leukemia Patients Undergoing Induction Chemotherapy

Hyunkyung Park, MD, Youk Jeonghwan, Wan Beom Park, MD PhD, Dong-Yeop Shin, MDPhD, Junshik Hong, MD, Inho Kim, MD PhD, Kim Nam Joong, Hyun Jung Lee, MD, Hyo Jung Kim, MD PhD, Sung-Soo Yoon, MD PhD, Youngil Koh, MD

Blood (2017) 130 (Supplement 1): 5033.

https://doi.org/10.1182/blood.V130.Suppl_1.5033.5033

Published: 2017

Journal Articles

Published abstracts at international meetings often over- or underestimate the initial response rate

Ofrat Beyar-Katz, Jacob M. Rowe, Lauren E. Townsend, Martin S. Tallman, Rivka Hadomi, Netanel A. Horowitz

Blood (2017) 129 (16): 2326–2328.

https://doi.org/10.1182/blood-2017-01-763144

Published: 2017

Includes: Supplemental data

Journal Articles

Utility of Next Generation Sequencing in Prognostication and Therapeutic Decision Making in Cytogenetically Normal AML with DNMT3A Mutations

Arjun Datt Law, MBBS, MDDM, Mahadeo A. Sukhai, BSc, MSc, PhD, Mariam Thomas, PhD, Andrea Arruda, MSc., Narmin Ibrahimova, Steven M. Chan, MD PhD, Vikas Gupta, MD FRCP, FRCPath, Mark D. Minden, MD PhD, Aaron D. Schimmer, MD PhD, Hassan Sibai, MD, Karen W.L. Yee, MD, Dwayne L. Barber, PhD, Tracy L. Stockley, PhD, Suzanne Kamel-Reid, PhD DABMG, FACMG, Andre C. Schuh, MD FRCPC

Blood (2016) 128 (22): 2886.

https://doi.org/10.1182/blood.V128.22.2886.2886

Published: 2016

Journal Articles

Probing Co-Operating Somatic Mutations in MLL-ENL Driven Leukemogenesis

Amol Sanjay Ugale, PhD, Sofia Adolfsson, PhD, Petter Säwén, Monika Dudenhöffer-Pfeifer, PhD, David Bryder

Blood (2016) 128 (22): 2855.

https://doi.org/10.1182/blood.V128.22.2855.2855

Published: 2016

Journal Articles

Prognostic Impact of Molecular Response Assessed By Next-Generation Sequencing in a Large Cohort of Multiple Myeloma Patients

Beatriz Sanchez-Vega, PhD, Rafael Alonso, MD, Isabel Cuenca, Santiago Barrio, PhD, Yanira Ruiz-Heredia, Carlos Marin, Inmaculada Rapado, PhD, Cristina Jimenez, BSc, Xabier Aguirre, Rosa M. Ayala, MD PhD, Teresa Cedena, Bruno Paiva, PhD, Maria-Victoria Mateos, MD PhD, Laura Rosiñol, Joan Bladé, Jesus San Miguel, MD PhD, Ramon Garcia-Sanz, MD PhD, Juan José Lahuerta, MDPhD, Joaquín Martínez-López, MD PhD

Blood (2016) 128 (22): 3283.

https://doi.org/10.1182/blood.V128.22.3283.3283

Published: 2016

Journal Articles

Hematological Parameters As Exclusion Criteria in Clinical Trials of Acute Coronary Syndrome

Ohad Oren, MD, Douglas F. Beach, MD

Blood (2016) 128 (22): 3593.

https://doi.org/10.1182/blood.V128.22.3593.3593

Published: 2016

Journal Articles

Distribution of 9p24 Abnormalities in Hematologic Malignancies with an Emphasis on Diffuse Large B-Cell Lymphoma

Dilan Patel, MD, Jamie Riney, MD, Andrew Hahn, MD, Matthew K Stein, MD, Michael G. Martin, MD

Blood (2016) 128 (22): 1866.

https://doi.org/10.1182/blood.V128.22.1866.1866

Published: 2016

NARROW

Comparison of Clinical Evolution of Children with Sickle Cell Disease before and after Treatment with Hydroxyurea at Saint Damien Hospital, Tabarre-Haiti,2013-2018

A Study of Haemostatic Parameters in Patients with Philadelphia-Negative Myeloproliferative Neoplasms. Correlation with, Clinical, Laboratory, Molecular, and Treatment Characteristics

Evaluation of Infusion Reactions in Patients Receiving Daratumumab Post-Implementation of an Augmented Pre- and Peri-Medication Regimen

Indirect Comparison Using Individual Patient Level Data Comparing Efficacy and Safety of a Daratumumab Monotherapy Vs. EU Approved Comparator Therapies in Patients with Multiple Myeloma

Successful Field Test of a Combined Health Access Strategy and Novel Device to Screen for Sickle Cell Disease (SCD) in Rural Sub-Saharan Africa

Consistent Benefit of L-Glutamine Observed across Patients with Low, Medium, and High Number of Crises Reported in the Year Prior to Screening -- Analysis from the Phase 3 Study of L-Glutamine in Sickle Cell Anemia

Black Patients Experience Highest Rates of Specific Cancer-Associated Venous Thromboembolism: A Study Based at a Large Safety-Net Hospital in New England

Practice and Correlates of Cancer Associated Thrombosis: The Impact of Socioeconomic Status

Identification of Functional Determinants of Response and Resistance to CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy of Chronic Lymphocytic Leukemia

Thrombin Generation As a Predictive Biomarker for Venous Thromboembolism in Patients with Pancreatic and Lung Cancer Undergoing Systemic Therapy

Exceptional Responses to Epigenetic Based Therapy in Pediatric and Young Adult Monosomy 7 MDS/AML Patients with and without TP53 Mutations

Coagulation Activation in Brain Neoplasms

miRNA Profiling in Pediatric T-ALL with Use of Next-Generation Sequencing: Focus on T-ALL Pathobiology and Heterogeneity

Mycafungin Prophylaxis for Adult Acute Leukemia Patients Undergoing Induction Chemotherapy

Published abstracts at international meetings often over- or underestimate the initial response rate

Utility of Next Generation Sequencing in Prognostication and Therapeutic Decision Making in Cytogenetically Normal AML with DNMT3A Mutations

Probing Co-Operating Somatic Mutations in MLL-ENL Driven Leukemogenesis

Prognostic Impact of Molecular Response Assessed By Next-Generation Sequencing in a Large Cohort of Multiple Myeloma Patients

Hematological Parameters As Exclusion Criteria in Clinical Trials of Acute Coronary Syndrome

Distribution of 9p24 Abnormalities in Hematologic Malignancies with an Emphasis on Diffuse Large B-Cell Lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only